← Open Payments lookup

PHILLIP GULLEY: Open Payments

NPI 1346832854 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,069 in 197 payments from 31 companies in 2025. Trend: 2023 $4,744 · 2024 $4,916 · 2025 $4,069

Food & beverage: $4,040Education: $28
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.25$521
UCB, Inc.13$426
ABBVIE INC.25$407
Lundbeck LLC22$376
Celgene Corporation18$318
Novartis Pharmaceuticals Corporation12$229
Neurelis, Inc.6$176
JAZZ PHARMACEUTICALS INC.6$143
TG Therapeutics, Inc.10$139
Janssen Biotech, Inc.4$117

Products named: INGREZZA, ZEPOSIA, VYEPTI, KESIMPTA, UBRELVY, QULIPTA, VALTOCO, REXULTI.

Industry payments across TX — which companies pay providers there.